Quoc-Dien Trinh, MD, has been awarded a $250K American Cancer Society/Pfizer Inc., grant for the study, “Understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer.”
Preliminary research has identified significant racial disparities in receipt of definitive therapy for men in Massachusetts who are diagnosed with intermediate and high-risk localized prostate cancer. The overall goal of the study is to use a comparative case study approach to identify factors, processes, programs and practices associated with receipt of definitive therapy and develop interventions to encourage appropriate care for Black men with prostate cancer.
Quoc-Dien Trinh, MD
Associate Surgeon, Division of Urology, Brigham and Women’s Hospital
Director, Ambulatory Clinical Operations, Division of Urology, Brigham and Women’s Hospital
Co-Director, Prostate Cancer Center, Dana-Farber/Brigham and Women’s Cancer Center
Associate Professor of Surgery, Harvard Medical School
Dr. Trinh is an associate professor of surgery at Harvard Medical School, director of Ambulatory Clinical Operations in the Division of Urology at Brigham and Women’s Hospital, and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center. He is also a core faculty member at the Center for Surgery and Public Health. Dr. Trinh’s research focuses primarily on inequity and outcomes of cancer care. His publications include over 500 peer-reviewed articles, book chapters and videos. His research has been funded by the American Society of Clinical Oncology (ASCO), the Prostate Cancer Foundation (PCF), the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), among others. Dr. Trinh received his medical degree from the Université de Montréal in Canada, where he also completed his residency training in urology. He completed his fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute.